Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Jun;84(11):3673–3677. doi: 10.1073/pnas.84.11.3673

Anti-idiotypic antibodies as probes of protein active sites: application to cholera toxin subunit B.

D S Ludwig, R A Finkelstein, A E Karu, W S Dallas, E R Ashby, G K Schoolnik
PMCID: PMC304937  PMID: 3473474

Abstract

Since Jerne proposed a "network" theory of immune regulation, the properties of anti-idiotypic antibodies (anti-IdAb) have been investigated widely. Anti-IdAb raised against antibodies to a variety of ligands have been shown to bind the ligands' receptors. Thus, the combining site of an anti-IdAb may contain information regarding the three-dimensional structure of an antigen. However, this remarkable property of "internal imagery" has not been exploited for structural investigation at the molecular level. In the present report, a monoclonal "auto"-anti-IdAb was raised against ganglioside GM1 (a cell-surface glycolipid that binds cholera toxin) and was shown to crossreact with the B subunit of cholera toxin. This antibody was presumed to recognize amino acid residues located within the GM1 binding domain. To identify these residues, the antibody was screened against homologous toxins purified from enterotoxigenic strains of Escherichia coli and chimeric peptides produced by recombinant methods. Amino acid variation at position 4 from the N terminus of these proteins was found to disrupt antibody binding. Since the toxins and chimera are all closely related in structure and function, the residue at position 4 (an asparagine in cholera toxin B subunit) appears to be in the epitope of the antibody and, by implication, in the GM1 binding site. Of particular significance, this structural detail could not be deduced with GM1 alone. It would seem that ligand and anti-ligand anti-IdAb encode similar stereochemical information but do so with different "chemical alphabets," giving rise to distinct binding specificities.

Full text

PDF
3673

Images in this article

3676Image
on p.3676
3676Image
on p.3676

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bolton A. E., Hunter W. M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973 Jul;133(3):529–539. doi: 10.1042/bj1330529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cassel D., Pfeuffer T. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2669–2673. doi: 10.1073/pnas.75.6.2669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen E. Y., Seeburg P. H. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA. 1985 Apr;4(2):165–170. doi: 10.1089/dna.1985.4.165. [DOI] [PubMed] [Google Scholar]
  5. Clements J. D., Finkelstein R. A. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect Immun. 1979 Jun;24(3):760–769. doi: 10.1128/iai.24.3.760-769.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleveland W. L., Wassermann N. H., Sarangarajan R., Penn A. S., Erlanger B. F. Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism. Nature. 1983 Sep 1;305(5929):56–57. doi: 10.1038/305056a0. [DOI] [PubMed] [Google Scholar]
  7. Couraud J. Y., Escher E., Regoli D., Imhoff V., Rossignol B., Pradelles P. Anti-substance P anti-idiotypic antibodies. Characterization and biological activities. J Biol Chem. 1985 Aug 5;260(16):9461–9469. [PubMed] [Google Scholar]
  8. Cuatrecasas P. Interaction of Vibrio cholerae enterotoxin with cell membranes. Biochemistry. 1973 Aug 28;12(18):3547–3558. doi: 10.1021/bi00742a031. [DOI] [PubMed] [Google Scholar]
  9. DE S. N. Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature. 1959 May 30;183(4674):1533–1534. doi: 10.1038/1831533a0. [DOI] [PubMed] [Google Scholar]
  10. DUTTA N. K., PANSE M. V., KULKARNI D. R. Role of cholera a toxin in experimental cholera. J Bacteriol. 1959 Oct;78:594–595. doi: 10.1128/jb.78.4.594-595.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dallas W. S., Falkow S. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature. 1980 Dec 4;288(5790):499–501. doi: 10.1038/288499a0. [DOI] [PubMed] [Google Scholar]
  12. De Wolf M. J., Fridkin M., Epstein M., Kohn L. D. Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. J Biol Chem. 1981 Jun 10;256(11):5481–5488. [PubMed] [Google Scholar]
  13. De Wolf M. J., Fridkin M., Kohn L. D. Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. J Biol Chem. 1981 Jun 10;256(11):5489–5496. [PubMed] [Google Scholar]
  14. De Wolf M., Van Dessel G., Lagrou A., Hilderson H. J., Dierick W. Structural features of the binding site of cholera toxin inferred from fluorescence measurements. Biochim Biophys Acta. 1985 Nov 29;832(2):165–174. doi: 10.1016/0167-4838(85)90328-0. [DOI] [PubMed] [Google Scholar]
  15. Duffy L. K., Lai C. Y. Involvement of arginine residues in the binding site of cholera toxin subunit B. Biochem Biophys Res Commun. 1979 Dec 14;91(3):1005–1010. doi: 10.1016/0006-291x(79)91979-x. [DOI] [PubMed] [Google Scholar]
  16. Finkelstein R. A., Boesman M., Neoh S. H., LaRue M. K., Delaney R. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen). J Immunol. 1974 Jul;113(1):145–150. [PubMed] [Google Scholar]
  17. Finkelstein R. A., Burks M. F., Rieke L. C., McDonald R. J., Browne S. K., Dallas W. S. Application of monoclonal antibodies and genetically-engineered hybrid B-subunit proteins to the analysis of the cholera/coli enterotoxin family. Dev Biol Stand. 1985;59:51–62. [PubMed] [Google Scholar]
  18. Fishman P. H., Moss J., Osborne J. C., Jr Interaction of choleragen with the oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide binding sites. Biochemistry. 1978 Feb 21;17(4):711–716. doi: 10.1021/bi00597a024. [DOI] [PubMed] [Google Scholar]
  19. Galanos C., Lüderitz O., Westphal O. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem. 1971 Dec 22;24(1):116–122. doi: 10.1111/j.1432-1033.1971.tb19661.x. [DOI] [PubMed] [Google Scholar]
  20. Geary S. J., Marchlewicz B. A., Finkelstein R. A. Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli. Infect Immun. 1982 Apr;36(1):215–220. doi: 10.1128/iai.36.1.215-220.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gill D. M., Meren R. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3050–3054. doi: 10.1073/pnas.75.7.3050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gill D. M. The arrangement of subunits in cholera toxin. Biochemistry. 1976 Mar 23;15(6):1242–1248. doi: 10.1021/bi00651a011. [DOI] [PubMed] [Google Scholar]
  23. Kurosky A., Markel D. E., Peterson J. W. Covalent structure of the beta chain of cholera enterotoxin. J Biol Chem. 1977 Oct 25;252(20):7257–7264. [PubMed] [Google Scholar]
  24. Lai C. Y. Determination of the primary structure of cholera toxin B subunit. J Biol Chem. 1977 Oct 25;252(20):7249–7256. [PubMed] [Google Scholar]
  25. Ledeen R. W., Yu R. K. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 1982;83:139–191. doi: 10.1016/0076-6879(82)83012-7. [DOI] [PubMed] [Google Scholar]
  26. Leong J., Vinal A. C., Dallas W. S. Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin. Infect Immun. 1985 Apr;48(1):73–77. doi: 10.1128/iai.48.1.73-77.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lindholm L., Holmgren J., Wikström M., Karlsson U., Andersson K., Lycke N. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect Immun. 1983 May;40(2):570–576. doi: 10.1128/iai.40.2.570-576.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ludwig D. S., Holmes R. K., Schoolnik G. K. Chemical and immunochemical studies on the receptor binding domain of cholera toxin B subunit. J Biol Chem. 1985 Oct 15;260(23):12528–12534. [PubMed] [Google Scholar]
  29. Ludwig D. S., Ribi H. O., Schoolnik G. K., Kornberg R. D. Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8585–8588. doi: 10.1073/pnas.83.22.8585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marasco W. A., Becker E. L. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil. J Immunol. 1982 Feb;128(2):963–968. [PubMed] [Google Scholar]
  31. Markel D. E., Hejtmancik K. E., Peterson J. W., Kurosky A. Structure, function, and antigenicity of cholera toxin. J Supramol Struct. 1979;10(2):137–149. doi: 10.1002/jss.400100204. [DOI] [PubMed] [Google Scholar]
  32. Sattler J., Schwarzmann G., Staerk J., Ziegler W., Wiegandt H. Studies of the ligand binding to cholera toxin, II. The hydrophilic moiety of sialoglycolipids. Hoppe Seylers Z Physiol Chem. 1977 Feb;358(2):159–163. doi: 10.1515/bchm2.1977.358.1.159. [DOI] [PubMed] [Google Scholar]
  33. Schreiber A. B., Couraud P. O., Andre C., Vray B., Strosberg A. D. Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7385–7389. doi: 10.1073/pnas.77.12.7385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sege K., Peterson P. A. Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci U S A. 1978 May;75(5):2443–2447. doi: 10.1073/pnas.75.5.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sugasawara R. J., Prato C. M., Sippel J. E. Enzyme-linked immunosorbent assay with a monoclonal antibody for detecting group A meningococcal antigens in cerebrospinal fluid. J Clin Microbiol. 1984 Feb;19(2):230–234. doi: 10.1128/jcm.19.2.230-234.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tsuji T., Honda T., Miwatani T., Wakabayashi S., Matsubara H. Analysis of receptor-binding site in Escherichia coli enterotoxin. J Biol Chem. 1985 Jul 15;260(14):8552–8558. [PubMed] [Google Scholar]
  37. Wiegandt H., Bücking H. W. Carbohydrate components of extraneuronal gangliosides from bovine and human spleen, and bovine kidney. Eur J Biochem. 1970 Aug;15(2):287–292. doi: 10.1111/j.1432-1033.1970.tb01006.x. [DOI] [PubMed] [Google Scholar]
  38. Wiegandt H., Ziegler W. The use of reductaminated sugars for the preparation of oligosaccharide conjugates, I. Synthetic glycolipids containing glycosphingolipid-derived oligosaccharides. Hoppe Seylers Z Physiol Chem. 1974 Jan;355(1):11–18. doi: 10.1515/bchm2.1974.355.1.11. [DOI] [PubMed] [Google Scholar]
  39. Yamamoto T., Yokota T. Sequence of heat-labile enterotoxin of Escherichia coli pathogenic for humans. J Bacteriol. 1983 Aug;155(2):728–733. doi: 10.1128/jb.155.2.728-733.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES